According to Editas Medicine
's latest financial reports the company has $0.34 B in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2023-12-31 | $0.34 B | -3.21% |
2022-12-31 | $0.36 B | -34.85% |
2021-12-31 | $0.55 B | 40.67% |
2020-12-31 | $0.39 B | 49.97% |
2019-12-31 | $0.26 B | 11.13% |
2018-12-31 | $0.23 B | 13.5% |
2017-12-31 | $0.20 B | 54.58% |
2016-12-31 | $0.13 B | -261.95% |
2015-12-31 | $-83.12 M | 443.51% |
2014-12-31 | $-15.3 M | 767.39% |
2013-12-31 | $-1.77 M |
Company | Net assets | differencediff. | Country |
---|---|---|---|
Organovo ONVO | $6.18 M | -98.23% | ๐บ๐ธ USA |
Orchard Therapeutics
ORTX | $80.25 M | -77.01% | ๐ฌ๐ง UK |
Novavax NVAX | -$0.72 B | -305.37% | ๐บ๐ธ USA |
Novocure
NVCR | $0.36 B | 3.84% | Jersey |